...
首页> 外文期刊>Patient Safety in Surgery >Echinomycin did not affect the safety of fracture healing: an experimental pilot study on a murine femur fracture model
【24h】

Echinomycin did not affect the safety of fracture healing: an experimental pilot study on a murine femur fracture model

机译:棘霉素未影响骨折愈合的安全性:鼠股骨骨折模型的实验性初步研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

There is a need for effective drugs in the prevention and treatment of heterotopic ossifications (HO) after fractures. Echinomycin has been shown to prevent formation of HO in an animal model. However, before it may be considered as an option against HO, it needs to be studied whether it prevents fracture healing similar to non-steroidal anti-inflammatory drugs (NSAIDS). Therefore, the hypothesis was that echinomycin prevents?fracture healing and callus formation. In an experimental murine pilot study, standard blunt femur fractures were induced and retrograde intramedullary compression fixation of the femur was performed. The treatment group (n?=?8) received echinomycin (0.3?mg/kg body weight) and the control group (n?=?8) did not receive echinomycin. The fractures and implant positions were verified by conventional X-rays immediately postoperatively. As the primary outcome variable, fracture healing (osseous consolidation) was evaluated by conventional X-rays and micro-computed tomography (CT) scans after ten weeks and graded as healed, partial or complete pseudarthrosis. The secondary outcome, callus formation, was graded semi-quantitatively from 0 (mostly?absent) to 3 (maximum). Fracture healing was present in all living cases after ten weeks concerning the treatment group. Partial pseudarthrosis was seen in two cases, one in the treatment and another one in the control group. Complete pseudarthrosis was seen in one case of the control group after an open fracture. Callus formation was similar in both groups with a mean grade of 1.5 within each group. Two cases of the treatment group died. As a novel finding, echinomycin did not inhibit fracture healing or callus formation in this in vivo murine standard femur fracture model pilot study. Further studies involving a larger number of cases, quantitative assessment with CT scans and histopathological analysis are needed before generalizing the results of this pilot study.
机译:需要有效的药物来预防和治疗骨折后的异位骨化(HO)。棘霉素在动物模型中已显示可预防HO的形成。但是,在被认为是抗HO的选择之前,需要像非甾体抗炎药(NSAIDS)一样研究它是否可以防止骨折愈合。因此,假说是棘霉素可防止骨折愈合和愈伤组织形成。在一项实验性的鼠实验研究中,诱发了标准的钝性股骨骨折,并进行了股骨的逆行髓内加压固定。治疗组(n≥= 8)接受棘霉素(0.3μmg/ kg体重),对照组(n≥= 8)未接受棘霉素。术后立即通过常规X射线检查骨折和植入物位置。作为主要的预后变量,十周后通过常规X射线和显微计算机断层扫描(CT)扫描评估骨折愈合(骨巩固),并分为愈合,部分或完全假关节。次要结果,愈伤组织形成,从0(大部分不存在)到3(最大)半定量分级。与治疗组相关的所有患者在十周后均出现骨折愈合。在两例中发现部分假关节,一例在治疗中,另一例在对照组。在开放性骨折后,对照组的一例可见完全假关节。两组的愈伤组织形成相似,每组平均等级为1.5。治疗组有2例死亡。作为一个新发现,在该体内鼠标准股骨骨折模型先导研究中,棘霉素未抑制骨折愈合或愈伤组织形成。在推广此试验研究的结果之前,需要进行涉及大量病例的进一步研究,CT扫描定量评估和组织病理学分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号